Cv_quante_word

Dr. med. Arnim Quante
Curriculum Vitae
Seit 2009| Oberarzt des Moduls "Integrative Psychiatrie" mit Leitung des Konsiliardienstes der Charité, Campus Benajamin Franklin, Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Berlin Seit 2008| Facharzt für Psychiatrie und Psychotherapie 2003 - 2009 | Wissenschaftlicher Mitarbeiter an der Charité, Campus Bnejamin Franklin, Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Berlin 2002 - 2003 | Arzt im Praktikum an der Neurologischen Klinik des Auguste-Viktoria- 2002 | Promotion zum Thema "Zytokine im Nabelschnurblut zur Früherkennung einer neonatalen Infektion", Leitung Prof. J.W. Dudenhausen 2001 - 2002 | Praktisches Jahr: Innere Medizin im Wenckebach-Klinikum Berlin, Chirurgie an der University of Natal in Südafrika, Psychiatrie am Klinikum Neukölln in Berlin 1994 - 2001 | Studium der Humanmedizin an der Medizinischen Fakultät der Universität Rostock sowie der Freien Universität Berlin Forschungs- und Interessensschwerpunkte
Psychopharmakologie Affektive Störungen Bipolare Störung Stimulationsverfahren Ad hoc Reviews (Auswahl)
International Journal of Psychiatry and Clinical Practice Neurology, Psychiatry and Brain Research RöFo – Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Publikationsliste (Auswahl)
Mews MR, Rombold F, Quante A. Low-dose doxepin fails to improve sleep disturbances in depressed patients – a retrospective case series. Prim Care Companion CNS Tauch D, Winkel S, Quante A. Psychiatric Consultations and Therapy Recommendations Following a Suicide Attempt in a General Hospital and their Associations with selected Parameters in a One Year Period. Int J Psychiatry Clin Pract. In press. Anderson C, George D, Quante A. Pregabalin in acute treatment of anxious depression: A case series. Psych Res. DOI: 10.1016/j.psychres.2013.10.007 Quante A, Regen F, Schindler F, Volkmer K, Severus E, Urbanek C, Luborzewski A, Roepke S, Anghelescu I. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study. Psychiatr Danub. 2013 Sep;25(3):214-20. Zeugmann S, Buehrsch N, Bajbouj M, Heuser I, Anghelescu I, Quante A. Childhood maltreatment and adult proinflammatory status in patients with major depression. Psychiatr Danub. 2013 Sep;25(3):227-35. Mews MR, Quante A. Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder: a retrospective case series and review of the literature. J Clin Psychopharmacol. 2013 Aug;33(4):512-9 Quante A, Zeugmann S. Tranylcypromine and bupropion combination therapy in treatment-resistant major depression: a report of 2 cases. J Clin Psychopharmacol. 2012 Aug;32(4):572-4. Zeugmann S, Quante A, Popova-Zeugmann L, Kössler W, Heuser I, Anghelescu I. Pathways linking early life stress, metabolic syndrome, and the inflammatory marker fibrinogen in depressed inpatients. Psychiatr Danub. 2012 Mar;24(1):57-65. Bernard F, Quante A. Acoustic hallucinations and pseudo-hallucinations in acquired deafness : Antipsychotic treatment. HNO. 2011 Mar 18. Merkl A, Schubert F, Quante A, Luborzewski A, Brakemeier EL, Grimm S, Heuser I, Bajbouj M. Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy. Biol Psychiatry. 2011 Apr 15;69(8):772-9. Epub 2010 Oct 16. Roepke S, Luborzewski A, Schindler F, Quante A, Anghelescu I, Heuser I, Bajbouj M. Stimulus Pulse-Frequency-Dependent Efficacy and Cognitive Adverse Effects of Ultrabrief-Pulse Electroconvulsive Therapy in Patients With Major Depression. J ECT. 2010 Oct 5. Quante A, Zeugmann S, Regen F, Engelhardt A, Anghelescu IG. Psychopharmacological treatment status in outpatients with bipolar disorder: a clinical survey in Germany. Psychiatry Investig. 2010 Sep;7(3):155-62. Quante A, Luborzewski A, Brakemeier EL, Merkl A, Danker-Hopfe H, Bajbouj M. Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: A randomized, double-blind pilot study. J Psychiatr Res. 2010 Aug 19. Quante A, Zeugmann S, Luborzewski A, Schommer N, Langosch J, Born C, Anghelescu I, Wolf J. Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. Hum Psychopharmacol.2010 Mar 1;25(2):126-132 Zeugmann S, Quante A, Heuser I, Schwarzer R, Anghelescu I. Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome. J Clin Psychiatry. 2010 Feb 9. Quante A, van Hall F, Anghelescu I. Psychopharmacological combination therapy in bipolar disorder. Fortschr Neurol Psychiatr. 2009 May;77(5):252-62. Anghelescu I, Klawe C, Singer P, Fehr C, Hiemke C, Quante A, Regen F, Dahmen N, Szegedi A. Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene. World J Biol Psychiatry. 2009 Jan 30:1-8. Lauterbach E, Felber W, Mueller-Oerlinghausen B, Ahrens B ,Bronisch T ,Meyer T ,Kilb B ,Lewitzka U ,Hawellek B ,Quante A, Richter K, Broocks A, Hohagen F. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand.:2008. Jakob F, Brakemeier EL, Schommer NC, Quante A, Merkl A, Danker-Hopfe H, Anghelescu I, Heuser I, Bajbouj M.: Ultrahigh Frequency Repetitive Transcranial Magnetic Stimulation in Unipolar Depression. J Clin Psychopharmacol. 2008 Aug;28(4):474-476. Quante A, Jakob F, Wolf J.: Depression preceding the onset of progressive supranuclear paralysis: a case report. J Neuropsychiatry Clin Neurosci. 2008 Spring; 20(2):247-8. Quante A, Röpke S, Merkl A, Anghelescu I, Lammers CH.: Psychopharmacologic treatment of personality disorders. Fortschr Neurol Psychiatr. 2008 Mar;76(3):139-46. Quante A, Zeugmann S, Bajbouj M, Anghelescu I.: Clozapine in medication- and electroconvulsive therapy-resistant, depressed inpatients: a case series. J. Clin Psychopharmacol. 2007 Dec;27(6):715-7. Dettling M, Opgen-Rhein C, Quante A, Anghelescu I.: Fluoxetine for treatment of anorexia nervosa. JAMA. 2006 Nov 22; 296(20):2439-40. Quante A, Anghelescu I: „Ziprasidone in the treatment of bipolar disorder“, Die Psychiatrie Klein JP, Fiedler U, Appel H, Quante A, Jockers-Scherübl MC.: Massive creatine kinase elevations with quetiapine: report of two cases. Pharmacopsychiatry. 2006 Jan;39(1):39-40.

Source: http://psychiatrie.charite.de/fileadmin/user_upload/microsites/m_cc15/psychiatrie/Mitarbeiter/cvs/quante/cv_quante_d.pdf

Doi:10.1016/s0166-6851(03)00174-9

Molecular & Biochemical Parasitology 131 (2003) 77–81The H region HTBF gene mediates terbinafine resistanceJulio F.M. Marchini , Angela K. Cruz , Stephen M. Beverley , Luiz R.O. Tosi a Departamento de Biologia Celular e Molecular e Bioagentes Patogˆenicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ave. Bandeirantes, 3900, 14049-900 Ribeirão Preto�

Some type of interview with authors about a general subject, co

Silica, Nature’s Surgeon Experts believe higher blood serum levels lead to hardening of the arteries, which can cause heart attacks. The authors of the study called for We all want to be beautiful, live longer, be a rethink on giving people calcium supplements healthier and feel better, but how do you know for bone health. "Serum calcium levels have what to do to achieve this? How of

© 2008-2018 Medical News